Efficacy of Intercostal CryoAnalgesia in Robotic Lung Resection

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 15, 2022

Primary Completion Date

October 4, 2024

Study Completion Date

December 31, 2024

Conditions
Pain, PostoperativeLung Diseases
Interventions
DEVICE

Intercostal Nerve Cryoablation

Patients will receive intraoperative intercostal nerve cryoablation using CryoICE® CRYOS-L cryoablation probes (AtriCure, Inc) to intercostal spaces 4th to 10th in thoracoabdominal aortic repairs and 4th to 8th in descending thoracic aortic repair cases prior to wound closure.

DRUG

Patient-controlled analgesia (PCA)

Patients will have access to the standard PCA (patient-controlled analgesia) offered at Froedtert Hospital. This includes tylenol 650 mg oral, robaxin 500 mg oral, and tramadol 25-50 mg oral. All patients will have the first two ports placed at which time an intercostal nerve block of nerves 4-9 will be performed using 0.5% Marcaine with Epinephrine.

Trial Locations (1)

53226

The Medical College of Wisconsin, Milwaukee

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

AtriCure, Inc.

INDUSTRY

lead

Medical College of Wisconsin

OTHER

NCT05144828 - Efficacy of Intercostal CryoAnalgesia in Robotic Lung Resection | Biotech Hunter | Biotech Hunter